NCT07051356

Brief Summary

The goal of this observational study is to evaluate whether AI-based analyses of wearable sensor data can identify early signs of deterioration leading to hospitalization in patients with advanced heart failure. The main questions it aims to answer are:

  • Can AI-driven analysis of wearable data detect physiological or behavioral changes associated with impending hospital admissions?
  • Does wearable-based remote monitoring influence daily exercise duration in patients with advanced heart failure.
  • Is wearable-based remote monitoring usable and acceptable for patients with advanced heart failure in a real-world setting? Participants will wear a wrist-worn (Fitbit) device continuously for one year and will use an eHealth app to answer question about their symptoms. Participant's physical activity, heart rate, heart rate variability, respiratory rate, sleep quality, and symptomatic status will be monitored remotely.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
15mo left

Started Jul 2025

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress41%
Jul 2025Aug 2027

First Submitted

Initial submission to the registry

May 26, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 4, 2025

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

July 4, 2025

Status Verified

June 1, 2025

Enrollment Period

2.1 years

First QC Date

May 26, 2025

Last Update Submit

June 25, 2025

Conditions

Keywords

Advanced heart failureWearable deviceArtificial intelligenceRemote monitoringLeft ventricular assist device

Outcome Measures

Primary Outcomes (1)

  • Algorithm Performance Metrics

    Algorithm's performance to detect imminent admission in patients with advanced HF will be measured by means of the following parameters: Accuracy, sensitivity, specificity, negative predictive value, positive predictive value, area under the ROC curve.

    From enrollment to the end of the monitoring period at 1 year.

Secondary Outcomes (2)

  • Change in daily exercise duration

    From baseline to the end of the monitoring period at 1 year.

  • Perceived usability

    At 1-year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who are under care at the UMC Utrecht due to advanced heart failure, are on the wating list for heart transplant or have received an LVAD as treatment (either as bridge to transplant or as destination therapy).

You may qualify if:

  • \>18 years.
  • Diagnosis of advanced heart failure, including at least one of the following major criteria.
  • LVAD implanted
  • Included on the waiting list for Heart transplant
  • Meeting the European Society of CArdiology criteria for advanced HF:
  • Severe and persistent symptoms of heart failure \[NYHA class III or IV\].
  • Severe cardiac dysfunction: according to ESC guidelines definition
  • ≥ 1 unplanned visit or hospitalization in the last 12 months requiring IV treatment.
  • Have access to a mobile phone or tablet with an operating system iSO 15 or Android 9 (or posterior versions of these systems).

You may not qualify if:

  • Impossibility to provide inform consent.
  • Impossibility to self-report data due to physical or mental disability.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UMC Utrecht

Utrecht, Netherlands

Location

Related Publications (4)

  • Schots BBS, Pizarro CS, Arends BKO, Oerlemans MIFJ, Ahmetagic D, van der Harst P, van Es R. Deep learning for electrocardiogram interpretation: Bench to bedside. Eur J Clin Invest. 2025 Apr;55 Suppl 1(Suppl 1):e70002. doi: 10.1111/eci.70002.

    PMID: 40191935BACKGROUND
  • Wang L, Zhou X. Detection of Congestive Heart Failure Based on LSTM-Based Deep Network via Short-Term RR Intervals. Sensors (Basel). 2019 Mar 28;19(7):1502. doi: 10.3390/s19071502.

    PMID: 30925693BACKGROUND
  • Huang JD, Wang J, Ramsey E, Leavey G, Chico TJA, Condell J. Applying Artificial Intelligence to Wearable Sensor Data to Diagnose and Predict Cardiovascular Disease: A Review. Sensors (Basel). 2022 Oct 20;22(20):8002. doi: 10.3390/s22208002.

    PMID: 36298352BACKGROUND
  • Truby LK, Rogers JG. Advanced Heart Failure: Epidemiology, Diagnosis, and Therapeutic Approaches. JACC Heart Fail. 2020 Jul;8(7):523-536. doi: 10.1016/j.jchf.2020.01.014. Epub 2020 Jun 10.

    PMID: 32535126BACKGROUND

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor. Head of the department of Cardiology, UMC Utrecht.

Study Record Dates

First Submitted

May 26, 2025

First Posted

July 4, 2025

Study Start

July 1, 2025

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

July 4, 2025

Record last verified: 2025-06

Locations